Research Roundup Neuroscience
Primary antibodies are a powerful tool in basic research. In our new research roundup dedicated to neuroscience, we talk about a mechanism responsible for drug resistance in epileptic patients and a newly discovered and evolutionarily conserved feature of oligodendrocytes.
Research Roundup: cancer research
Our new Research Roundup summarises three cancer research studies that have used polyclonal antibodies from Atlas Antibodies. Today we share insights into a new biomarker for glioma, the metastatic process in colorectal cancer, and the effect of ginseng metabolites on cancer cells proliferation. Learn more!
Research Roundup: cell biology
Do you love cell biology? Here for you are three new research studies showing our antibodies in action. This latest Research Roundup talks about kinesin’s motor domain in microtubules, membranes & trafficking in organelles, and lysosomal protein composition.
Research Roundup: stem cell research
Want to see our antibodies in action? Keep reading our latest Research Roundup! The following three studies have successfully utilized Atlas Antibodies products in stem cell research.
Research Roundup: diagnostic and prognostic cancer markers
Are you interested in seeing more of our antibodies in action? The following three studies have successfully utilized our antibodies to suggest or identify new biomarkers for different human cancers. Keep reading.
Research Roundup: see our neuroscience products in action
Our antibodies are used in cutting-edge neuroscience research around the world. Let's take a look at three recent studies showing our antibodies in action.
Research Roundup: Neuroscience Antibodies and Protein Standards
Our highly-validated antibodies and QPrEST protein standards are used in cutting-edge neuroscience research. Read a roundup of some newly published studies to see our neuroscience antibodies and targeted proteomics in action!
Research Roundup: prognostic biomarkers in cancer
Many of our cancer antibodies are used in cutting-edge research to identify new prognostic markers in different cancers. Let's take a look at three recent studies.